The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) has announced it is assessing new data on the potential risk of neurodevelopmental disorders (NDDs) in ...

In older people with dementia and epilepsy, starting treatment with valproate is linked to a higher risk for deaths than ...

Paternal use of the anti-seizure medication valproate during spermatogenesis was not associated with a risk of congenital malformations or neurodevelopmental disorders in offspring, an observational ...

Children whose fathers took valproate before conception were more likely to have neurodevelopmental disorders in a Nordic study. The risk of congenital malformations was not increased. Findings from ...

Details concerning the Sodium Valproate combination medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, liquids ...

Men taking sodium valproate are being warned to use contraception while on the medicine, because of "a potential small increased risk" of neurodevelopmental disorders in their future children, ...

Valproate-induced hyperammonemia is a serious but often under-recognised complication of valproic acid therapy, affecting patients receiving treatment for epilepsy, bipolar disorder and other ...

Valproate sodium 100mg/mL; soln for IV infusion after dilution; preservative-free. The mechanisms by which valproate exerts its therapeutic effects have not been established. It has been suggested ...

Catherine McNamara, from Hull, has three children who have been diagnosed with Fetal Valproate Spectrum Disorder A woman whose three children were born with disabilities after she was prescribed an ...

Children whose dads took valproate up to 3 months before conception were more likely to have neurodevelopmental disorders, data from Denmark, Norway, and Sweden showed. Compared with children whose ...